Evidence map›Paper›PMID 31198343›Full record

ArticleJournal of pharmacy & bioallied sciences2019

Analysis of Ki-67 Expression in Oral Premalignant Lesions and Normal Oral Mucosa: An Immunohistochemical Study.

Basheer H Beevi, Suhas Ramananda Nayak, Celestina D Peter, Ajay K Haridas, Lin Jacob, Asaf Aboobakker

Open access · goldAbstract read
In one paragraph

Article in Journal of pharmacy & bioallied sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 6 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Basheer H BeeviDepartment of Oral Pathology, Educare Institute of Dental Sciences, Malappuram, Kerala, India.
Suhas Ramananda NayakDepartment of Oral Pathology, Educare Institute of Dental Sciences, Malappuram, Kerala, India.
Celestina D PeterDepartment of Oral Pathology, Educare Institute of Dental Sciences, Malappuram, Kerala, India.
Ajay K HaridasDepartment of Oral Surgery, Educare Institute of Dental Sciences, Malappuram, Kerala, India.
Lin JacobDepartment of Oral Surgery, Educare Institute of Dental Sciences, Malappuram, Kerala, India.
Asaf AboobakkerDepartment of Oral Medicine and Radiology, Educare Institute of Dental Sciences, Malappuram, Kerala, India.
Noorul Islam College of Dental Science · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimThis study aimed to evaluate the Ki-67 expression in oral premalignant lesions and normal oral mucosa. MATERIALS AND

methodsThe cases were selected on the basis of the details obtained from the patients. A total of 45 specimens were divided into three groups: Group 1 (normal mucosa), Group 2 (clinically and histologically diagnosed as oral lichen planus), and Group 3 (clinically and histologically diagnosed as leukoplakia). Specimens were prepared and the slides for Ki-67 were observed under light microscope with a magnification of ×400. The tissue samples were thoroughly examined, and the pattern of expression was analyzed semiquantitatively by counting the number of positive cells.

resultsThe mean positive cell count of normal mucosa was 23.20 ± 2.89, of oral lichen planus was 42.82 ± 2.65, and of leukoplakia was 82.14 ± 3.10. There was a statistically significant difference of expression observed between the groups (

conclusionKi-67 is an easily applicable marker of cell proliferation whose expression correlates well with the disease progression.

Indexed as

Ki-67leukoplakianormal mucosaoral lichen planus

Identifiers

PMID31198343
PMCPMC6555373
OpenAlexW2947846089

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.